Amongst several mediators, tumor necrosis factor (TNF) and interleukin-6 (IL-6) were shown to promote both insulin resistance [73] and cardiac hypertrophy [74], suggesting that inflammation in metabolic syndrome might be a central feature in atherogenesis as well as in cardiac hypertrophy. Here, TNF is linked to metabolic syndrome.